Contrast-enhanced sonography of tumor neovascularity in a rabbit model

Ultrasound in Medicine and Biology

Volumn 24, Issue 4, 1998, Pages 495-501

  Brown, Janis M ^a   Quedens Case, Cara ^a   Alderman, Jonathan L ^a   Greener, Yigal ^b   Taylor, Kenneth J W ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Molecular Biosystems Inc   (United States)

Author keywords

Contrast media; Flow dynamics; Neoplasms; Ultrasound

Indexed keywords

CONTRAST MEDIA; IMPLANTS (SURGICAL); LIVING SYSTEMS STUDIES; MEDICAL IMAGING; MUSCLE; PHYSIOLOGICAL MODELS; ULTRASONIC IMAGING;

ULTRASONOGRAPHY;

ONCOLOGY;

ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; ECHOGRAPHY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; RABBIT; SOFT TISSUE TUMOR; TUMOR; TUMOR BLOOD FLOW;

EID: 0032076843     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-5629(98)00004-0     Document Type: Article

References (30)

1. Bourne T., Campbell S., Steer C., Whitehead M.I., Collins W.P. Transvaginal colour flow imaging A possible new screening technique for ovarian cancer . BMJ. 299:1989;1367-1370.
2. Burns P.N., Halliwell M., Wells P.N., Webb A.J. Ultrasonic Doppler studies of the breast. Ultrasound Med Biol. 8:1982;127-143.
3. Carroll B.A., Turner R.J., Tickner E.G., Boyle D.B., Young S.W. Gelatin encapsulated nitrogen microbubbles as ultrasonic contrast agents. Invest Radiol. 15:1980;260-266.
4. Fleischer A.C., Rodgers W.H., Rao B.K., Kepple D.M., Worrell J.A. Assessment of ovarian tumor vascularity with transvaginal color Doppler sonography. J Ultrasound Med. 10:1991;563-568.
5. Fobbe F., Ohnesorge I., Reichel M., Ernst O., Schuermann R. Transpulmonary contrast agent and color-coded duplex sonography First clinical experience . Radiology. 185:(P):1992;142.
6. Folkman J., Merler E., Abernathy C., Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med. 133:1971;275-288.
7. Goldberg B.B. Ultrasonic measurement of the aortic arch, right pulmonary artery, and left atrium. Radiology. 101:1971;383-390.
8. Goldberg B.B., Hilpert P.L., Burns P.N., Liu J.B., Newman L.M. Hepatic tumors Signal enhancement at Doppler US after intravenous injection of a contrast agent . Radiology. 177:1990;713-717.
9. Goldberg B.B., Liu J.B., Burns P.N., Merton D.A., Forsberg F. Galactose-based intravenous sonographic contrast agent experimental studies . J Ultrasound Med. 12:1993;463-470.
10. Gramiak R., Shah P.M. Echocardiography of the aortic root. Invest Radiol. 3:1968;356-366.
11. Greenberg R.S., Taylor G.A., Stapleton J.C., Hillsley C.A., Spinak D.S. Analysis of regional cerebral blood flow in dogs, with an experimental microbubble-based US contrast agent. Radiology. 201:1996;119-123.
12. Hykes D., Hedrick W., Starchman D. Ultrasound physics and instrumentation. 1985;Churchill Livingstone, New York.
13. Kudo M., Tomita S., Tochio H., Kashida H., Hirasa M. Hepatic focal nodular hyperplasia Specific findings at dynamic contrast-enhanced US with carbon dioxide microbubbles . Radiology. 179:1991;377-382.
14. 2 microbubbles . Radiology. 161:1986;701-705.
15. Mattrey R.F. Perfluorooctylbromide a new contrast agent for CT, sonography and MR imaging . AJR. 152:1989;247-252.
16. Mattrey R.F., Andre M.P. Ultrasonic enhancement of myocardial infarction with perfluorocarbon compounds in dogs. Am J Cardiol. 54:1984;206-210.
17. Mattrey R.F., Leopold G.R., van Sonnenberg E., Gosink B.B., Scheible R.W. Perfluorochemicals as liver- and spleen-seeking ultrasound contrast agents. J Ultrasound Med. 2:1983;173-176.
18. Merritt C.R.B. Doppler color flow imaging. J Clin Ultrasound. 15:1987;591-597.
19. Meyerowitz C.B., Fleischer A.C., Pickens D.R., et al. Quantification of tumor vascularity and flow with amplitude color Doppler sonography in an experimental model Preliminary results . J Ultrasound Med. 15:1996;827-833.
20. Ophir J., Parker K.J. Contrast agents in diagnostic ultrasound. Ultrasound Med Biol. 15:1989;319-333.
21. Ramos I.M., Taylor K.J., Kier R., Burns P.N., Snower D.P. Tumor vascular signals in renal masses Detection with Doppler US . Radiology. 168:1988;633-637.
22. Roelandt J. Contrast echocardiography. Ultrasound Med Biol. 8:1982;471-492.
23. Rubin J.M., Adler R.S., Fowlkes J.B., et al. Fractional moving blood volume estimation with power Doppler imaging. Radiology. 197:1995;183-190.
24. Sigelmann R.A., Reid J.M. Analysis and measurement of ultrasound backscattering from an ensemble of scatters excited by sine-wave bursts. J Acoust Soc Am. 53:1973;1351-1355.
25. Tanaka S., Kitamura T., Fujita M., Nakanishi K., Okuda S. Color Doppler flow imaging of liver tumors. AJR. 154:1990;509-514.
26. Taylor K.J., Ramos I., Carter D., Morse S.S., Snower D. Correlation of Doppler US tumor signals with neovascular morphological features. Radiology. 166:1988;57-62.
27. Valdes-Cruz L.M., Sahn D.J. Ultrasonic contrast studies for the detection of cardiac shunts. J Am Coll Cardiol. 3:1984;978-985.
28. Veltri A., Capello S., Faissola B., Spalluto F., Farinet S. Dynamic contrast-enhanced ultrasound with carbon dioxide microbubbles as adjunct to arteriography of liver tumors. Cardiovasc Intervent Radiol. 17:1994;133-137.
29. Wells P.T., Halliwell M., Skidmore R., Webb A.J., Woodcock J.P. Tumour detection by ultrasonic Doppler blood-flow signals. Ultrasonics. 15:1977;231-232.
30. Ziskin M.C., Bonakdarpour A., Weinstein D.P., Lynch P.R. Contrast agents for diagnostic ultrasound. Invest Radiol. 7:1972;500-505.